IP Library › Granted Patent US 9,492,402
Granted Patent B2
US 9,492,402 · App. 14/206,044 · Granted Nov 15, 2016

Formulation of curcuminoids with enhanced bioavailability of curcumin, demethoxycurcumin, bisdemethoxycurcumin and method of preparation and uses thereof

Inventor: Benny Antony (Ankamaly, IN)
A61K31/12A61K36/9066
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,492,402
App. No.
14/206,044
Granted
Nov 15, 2016
Kind
B2
Abstract

A formulation of curcuminoid mixture having curcumin, demethoxycurcumin and bisdemethoxycurcumin and an essential oil of turmeric having 45% Ar-turmerone. The formulation gives enhanced bioavailability of bisdemethoxycurcumin, demethoxycurcumin and curcumin for up to 10 hrs. The curcuminoid mixture has curcumin, demethoxycurcumin and bisdemethoxycurcumin in a weight/weight ratio ranging from about 0.8:1:1 to about 1:1.1:1.2. A process of preparing a formulation of curcuminoid mixture having curcumin, demethoxycurcumin and bisdemethoxycurcumin in 0.8:1:1 to 1:1:1:1.2 weight/weight ratio and an essential oil of turmeric having 45% Ar-turmerone. A formulation for improved biological activity and bioavailability and tissue distribution of curcumin, demethoxycurcumin and bisdemethoxycurcumin.

Claims (23)

1. A composition for enhanced bioavailability of curcumin, demethoxycurcumin and bisdemethoxycurcumin; the composition comprising a formulation containing

i) curcumin, demethoxvcurcumin and bisdemethoxvcurcumin at a weight ratio range from about 0.8:1:1 to about 1:1.1:1.2 and

ii) an essential oil of turmeric comprising 45% ar-turmerone;

wherein the formulation is made by the following method:

a) drying a rhizome of turmeric to form a dried turmeric rhizome,

b) powdering the dried turmeric rhizome to form a dried turmeric rhizome powder,

c) adding ethyl acetate to the dried turmeric rhizome powder of part (b) to obtain solution and a residue,

d) separating the residue from the solution,

e) removing ethyl acetate solvent from the solution of part (d) to form an ethyl acetate extract,

f) cooling the ethyl acetate extract to obtain crystals of curcuminoid and a liquid comprising a combination of an essential oil of turmeric and curcuminoids that did not crystallize;

g) steam distilling the liquid of part (f) to obtain essential oil of turmeric and a waste residue,

h) loading the waste residue onto a silica column;

i) washing the loaded silica column with methanol and collecting, from the total volume of methanol added to the column, three successive fractions of eluate, wherein the three fractions are the first, second and third fractions and combining the second and third fractions obtain a combined eluate;

j) concentrating the combined eluate of part (i) under heat and vacuum to obtain a concentrated, combined eluate,

k) drying the concentrated, combined eluate to obtain a dried methanol extract,

l) powdering the dried methanol extract to obtain a curcuminoid mixture powder,

m) suspending the curcuminoid mixture powder in water to form a suspension and adding the distilled, essential oil of turmeric of part (g) to the suspension to obtain a mixture,

n) homogenizing the mixture of part (m) to obtain a slurry, and

o) drying the slurry of part (n) under heat and vacuum to form a uniform blend;

wherein the uniform blend of part (o) is the formulation.

2. The composition of claim 1 , wherein a weight ratio of the curcuminoid mixture powder to essential oil of turmeric is about 10:1.

3. The composition of claim 1 , wherein a weight ratio of the curcuminoid mixture powder to essential oil of turmeric is about 12:1.

4. A method for treating depression in a subject in need thereof, comprising administering to a subject in need thereof, an effective amount of the composition of claim 1 .

Priority Claims (1)
IN 950CHE2010 · Apr 5, 2010 · national
Continuity (17)
Continuation In Part 14094725 · Dec 2, 2013
Division 13385717 · Mar 5, 2012
Division 12926985 · Dec 21, 2010
Division 12662740 · Apr 30, 2010
Division 11635599 · Dec 8, 2006
Continuation PCTIN2005000176 · May 30, 2005
Continuation 14206044
Continuation In Part 13674249 · Nov 12, 2012
Division 13506572 · Apr 30, 2012
Division 12926980 · Dec 21, 2010
Division 12073864 · Mar 11, 2008
Continuation In Part 11635599
Continuation In Part 14206044
Continuation In Part 13645031 · Oct 4, 2012
Continuation PCTIN2011000232 · Apr 4, 2011
Provisional Application 61794175 · Mar 15, 2013
Related Publication 20140193533A1 · Jul 10, 2014